Essential fatty acids as possible enhancers of the beneficial actions of probiotics

被引:55
作者
Das, UN [1 ]
机构
[1] EFA Sci LLC, Norwood, MA 02062 USA
关键词
D O I
10.1016/S0899-9007(02)00840-7
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
OBJECTIVES: I investigated whether there is a common link between essential fatty acids and probiotics, which have similar actions and benefits in atopy. METHODS: I made a critical review of the literature pertaining to the actions of essential fatty acids and probiotics on immune response and the interaction between them with particular reference to atopy. RESULTS: Colonization of the human gastrointestinal tract occurs in the first months and years of life. Probiotics are cultures of beneficial bacteria of healthy gut microflora, which reduce dietary antigen load and thus protect against atopy. A significant reduction in the risk of childhood asthma and other atopic conditions was reported in children who were exclusively breast-fed for at least 4 mo after birth. This beneficial action can be attributed to the immunomodulatory, nutritional, or other components of human milk Human breast milk is rich in long-chain polyunsaturated fatty acids (LCPUFAs), which have immunomodulatory actions. Probiotics and LCPUFAs modulate T-helper 1 and 2 responses, show antibioticlike actions, and alleviate changes related to allergic inflammation. LCPUFAs promote the adhesion of probiotics to mucosal surfaces, which augments the health-promoting effects of probiotics. CONCLUSIONS: In view of the similarity in their actions and because LCPUFAs promote the actions of probiotics, I believe that a combination of LCPUFAs and probiotics offer significant protection against atopy. It is likely that breast-feeding and probiotics are two naturally occurring, appropriate events in early human life that have significant health benefits. (C) Elsevier Science Inc. 2002.
引用
收藏
页码:786 / 789
页数:4
相关论文
共 56 条
[1]   Abrogation of oral tolerance by feeding encapsulated antigen [J].
Barone, KS ;
Reilly, MR ;
Flanagan, MP ;
Michael, JG .
CELLULAR IMMUNOLOGY, 2000, 199 (02) :65-72
[2]   Interleukin-10 regulation in normal subjects and patients with asthma [J].
Borish, L ;
Aarons, A ;
Rumbyrt, J ;
Cvietusa, P ;
Negri, J ;
Wenzel, S .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (06) :1288-1296
[4]   Immunology - Asthma: An epidemic in the absence of infection? [J].
Cookson, WOCM ;
Moffatt, MF .
SCIENCE, 1997, 275 (5296) :41-42
[5]  
DAS UN, 1991, ASIA PAC J PHARMACOL, V6, P317
[6]  
DAS UN, 1988, NUTRITION, V4, P337
[7]   INTERACTION(S) BETWEEN ESSENTIAL FATTY-ACIDS, EICOSANOIDS, CYTOKINES, GROWTH-FACTORS AND FREE-RADICALS - RELEVANCE TO NEW THERAPEUTIC STRATEGIES IN RHEUMATOID-ARTHRITIS AND OTHER COLLAGEN VASCULAR DISEASES [J].
DAS, UN .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1991, 44 (04) :201-210
[8]   BENEFICIAL EFFECT OF EICOSAPENTAENOIC AND DOCOSAHEXAENOIC ACIDS IN THE MANAGEMENT OF SYSTEMIC LUPUS-ERYTHEMATOSUS AND ITS RELATIONSHIP TO THE CYTOKINE NETWORK [J].
DAS, UN .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1994, 51 (03) :207-213
[9]  
DAS UN, 1995, MED SCI RES, V23, P723
[10]  
DAS UN, 1985, CAN MED ASSOC J, V132, P1985